142 related articles for article (PubMed ID: 26661660)
1. Visfatin is a positive predictor of bone mineral density in young survivors of acute lymphocytic leukemia.
Siviero-Miachon AA; Spinola-Castro AM; de Martino Lee ML; Calixto AR; Geloneze B; Lazaretti-Castro M; Guerra-Junior G
J Bone Miner Metab; 2017 Jan; 35(1):73-82. PubMed ID: 26661660
[TBL] [Abstract][Full Text] [Related]
2. Subcutaneous adipose tissue plays a beneficial effect on subclinical atherosclerosis in young survivors of acute lymphocytic leukemia.
Siviero-Miachon AA; Spinola-Castro AM; de Martino Lee ML; de Castro Monteiro CM; de Camargo Carvalho AC; Calixto AR; Geloneze B; Guerra-Junior G
Vasc Health Risk Manag; 2015; 11():479-88. PubMed ID: 26316772
[TBL] [Abstract][Full Text] [Related]
3. Cranial radiotherapy predisposes to abdominal adiposity in survivors of childhood acute lymphocytic leukemia.
Siviero-Miachon AA; Spinola-Castro AM; Lee ML; Andreoni S; Geloneze B; Lederman H; Guerra-Junior G
Radiat Oncol; 2013 Feb; 8():39. PubMed ID: 23433104
[TBL] [Abstract][Full Text] [Related]
4. Improvement in bone mineral density and body composition in survivors of childhood acute lymphoblastic leukemia: a 1-year prospective study.
Marinovic D; Dorgeret S; Lescoeur B; Alberti C; Noel M; Czernichow P; Sebag G; Vilmer E; Léger J
Pediatrics; 2005 Jul; 116(1):e102-8. PubMed ID: 15995009
[TBL] [Abstract][Full Text] [Related]
5. A link between bone mineral density and serum adiponectin and visfatin levels in acromegaly.
Sucunza N; Barahona MJ; Resmini E; Fernández-Real JM; Ricart W; Farrerons J; Rodríguez Espinosa J; Marin AM; Puig T; Webb SM
J Clin Endocrinol Metab; 2009 Oct; 94(10):3889-96. PubMed ID: 19723758
[TBL] [Abstract][Full Text] [Related]
6. Bone mineral density and markers of bone turnover in young adult survivors of childhood lymphoblastic leukaemia.
Hoorweg-Nijman JJ; Kardos G; Roos JC; van Dijk HJ; Netelenbos C; Popp-Snijders C; de Ridder CM; Delemarre-van de Waal HA
Clin Endocrinol (Oxf); 1999 Feb; 50(2):237-44. PubMed ID: 10396368
[TBL] [Abstract][Full Text] [Related]
7. Relation of adiponectin, visfatin and bone mineral density in patients with metabolic syndrome.
Iacobellis G; Iorio M; Napoli N; Cotesta D; Zinnamosca L; Marinelli C; Petramala L; Minisola S; D'Erasmo E; Letizia C
J Endocrinol Invest; 2011 Jan; 34(1):e12-5. PubMed ID: 20634640
[TBL] [Abstract][Full Text] [Related]
8. No difference between prednisolone and dexamethasone treatment in bone mineral density and growth in long term survivors of childhood acute lymphoblastic leukemia.
van Beek RD; de Muinck Keizer-Schrama SM; Hakvoort-Cammel FG; van der Sluis IM; Krenning EP; Pieters R; van den Heuvel-Eibrink MM
Pediatr Blood Cancer; 2006 Jan; 46(1):88-93. PubMed ID: 15926166
[TBL] [Abstract][Full Text] [Related]
9. Relationships of Bone Mineral Density to Whole Body Mass, Fat Mass and Fat-free Mass in Long-term Survivors of Acute Lymphoblastic Leukemia in Childhood.
Athale UH; Marriott CJC; Cranston A; McDonald P; Webber CE; Farncombe TH; Barr RD
J Pediatr Hematol Oncol; 2021 Jan; 43(1):12-17. PubMed ID: 32675554
[TBL] [Abstract][Full Text] [Related]
10. Bone mineral density, body composition, and height in long-term survivors of acute lymphoblastic leukemia in childhood.
van der Sluis IM; van den Heuvel-Eibrink MM; Hählen K; Krenning EP; de Muinck Keizer-Schrama SM
Med Pediatr Oncol; 2000 Oct; 35(4):415-20. PubMed ID: 11025472
[TBL] [Abstract][Full Text] [Related]
11. Bone mineral density in childhood survivors of acute lymphoblastic leukemia treated without cranial irradiation.
Brennan BM; Mughal Z; Roberts SA; Ward K; Shalet SM; Eden TO; Will AM; Stevens RF; Adams JE
J Clin Endocrinol Metab; 2005 Feb; 90(2):689-94. PubMed ID: 15562013
[TBL] [Abstract][Full Text] [Related]
12. Adipokines in young survivors of childhood acute lymphocytic leukemia revisited: beyond fat mass.
Siviero-Miachon AA; Spinola-Castro AM; Andreoni S; Lee MLM; Calixto AR; Geloneze B; Guerra-Junior G
Ann Pediatr Endocrinol Metab; 2020 Sep; 25(3):174-181. PubMed ID: 32871655
[TBL] [Abstract][Full Text] [Related]
13. Severity of reduced bone mineral density and risk of fractures in long-term survivors of childhood leukemia and lymphoma undergoing guideline-recommended surveillance for bone health.
Bloomhardt HM; Sint K; Ross WL; Rotatori J; Ness K; Robinson C; Carpenter TO; Chow EJ; Kadan-Lottick NS
Cancer; 2020 Jan; 126(1):202-210. PubMed ID: 31536650
[TBL] [Abstract][Full Text] [Related]
14. Little evidence of low bone mass in acute lymphoblastic leukemia survivors.
Muszynska-Roslan K; Panasiuk A; Latoch E; Krawczuk-Rybak M; Konstantynowicz J
J Clin Densitom; 2012; 15(1):108-15. PubMed ID: 21880524
[TBL] [Abstract][Full Text] [Related]
15. Chemerin, visfatin, and vaspin serum levels in relation to bone mineral density in patients with inflammatory bowel disease.
Terzoudis S; Malliaraki N; Damilakis J; Dimitriadou DA; Zavos C; Koutroubakis IE
Eur J Gastroenterol Hepatol; 2016 Jul; 28(7):814-9. PubMed ID: 26934527
[TBL] [Abstract][Full Text] [Related]
16. Dietary fat intake associated with bone mineral density among visfatin genotype in obese people.
Khorrami-Nezhad L; Mirzaei K; Maghbooli Z; Keshavarz SA
Br J Nutr; 2018 Jan; 119(1):3-11. PubMed ID: 29355093
[TBL] [Abstract][Full Text] [Related]
17. Growth hormone deficiency predicts cardiovascular risk in young adults treated for acute lymphoblastic leukemia in childhood.
Link K; Moëll C; Garwicz S; Cavallin-Ståhl E; Björk J; Thilén U; Ahrén B; Erfurth EM
J Clin Endocrinol Metab; 2004 Oct; 89(10):5003-12. PubMed ID: 15472198
[TBL] [Abstract][Full Text] [Related]
18. The limited screening value of insulin-like growth factor-I as a marker for alterations in body composition in very long-term adult survivors of childhood cancer.
Blijdorp K; van den Heuvel-Eibrink M; Pieters R; Boot A; Sluimer J; van der Lelij AJ; Neggers S
Pediatr Blood Cancer; 2012 Oct; 59(4):711-6. PubMed ID: 22162176
[TBL] [Abstract][Full Text] [Related]
19. The influence of Visfatin, RBP-4 and insulin resistance on bone mineral density in women with treated primary osteoporosis.
Mihai G; Gasparik AI; Pascanu IM; Cevei M; Hutanu A; Pop RM
Aging Clin Exp Res; 2019 Jun; 31(6):889-895. PubMed ID: 31054116
[TBL] [Abstract][Full Text] [Related]
20. [Markers of metabolic syndrome and peptides regulating metabolism in survivors of childhood acute lymphoblastic leukemia].
Skoczeń S; Tomasik P; Balwierz W; Surmiak M; Sztefko K; Galicka-Latała D
Przegl Lek; 2011; 68(9):592-6. PubMed ID: 22335007
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
